-transparent.png){kind=logo}
The effect of calcium dobesilate on the alteration of the blood-retinal barrier was studied in 41 adult-onset, non-insulin dependent diabetic patients with minimal or no retinopathy, randomly assigned to receive either oral calcium dobesilate (1000 mg twice daily) or a placebo for 12 months. The posterior vitreous value and the penetration ratio, determined by vitreous fluorophotometry, reflected stabilisation of blood-retinal barrier permeability in the calcium dobesilate patients and deterioration of blood retinal barrier in those given placebo. During the relatively short period of the study, one year, no significant change in microaneurysm and capillary closure gradings was observed. No side effects were associated with calcium dobesilate.
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
June 1998,
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
July 1995,
Klinische Monatsblatter fur Augenheilkunde,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
September 1974,
Revue medicale de Liege,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
December 2006,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
June 1978,
Ophthalmology,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
January 1969,
Bulletins et memoires de la Societe francaise d'ophtalmologie,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
January 2005,
Treatments in endocrinology,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
March 2010,
Investigative ophthalmology & visual science,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
January 1992,
Documenta ophthalmologica. Advances in ophthalmology,
E B Leite, and
M C Mota, and
J R de Abreu, and
J G Cunha-Vaz
January 1981,
Vestnik oftalmologii,
